Cardiac calcified thrombus is a rare non-neoplastic cardiac mass that can present like an intra-cardiac tumor. The finding of a calcified thrombus in the inferior vena cava is described in patients with permanent central venous line or in presence of recurrent pulmonary embolism. The aim of the study is to describe a rare case of cardiac calcified thrombus in patient without comorbidities. We report an extremely unusual case of a 73 year-old woman with a calcified thrombus between the inferior cava and the atrium who was admitted to hospital for an incidental evidence of a heart neoformation mimicking a myxoma at an echocardiogram exam, totally asymptomatic performed as a screening test after thyroidectomy. Surgical removal of cardiac mass is fundamental both to achieve the correct diagnosis and to avoid thromboembolic risks or inferior vena cava occlusion. In a patient without serious comorbidities, surgical excision can be performed without major risks.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jocs.14443 | DOI Listing |
J Cardiothorac Surg
January 2025
Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Background: A patient with acute myeloid leukemia (AML) presented with a cardiac mass of unknown nature. This case underscores the importance of careful monitoring and a multidisciplinary approach in managing and differentiation of rare cardiac complications in leukemia patients. It aims to improve diagnostic accuracy and therapeutic outcomes in similar challenging scenarios.
View Article and Find Full Text PDFFuture Cardiol
January 2025
Faculty of Medicine, Tanta University, Tanta, Egypt.
Background: Rotational atherectomy (RA) has been proven to treat coronary artery calcification (CAC) during percutaneous coronary intervention (PCI).
Purpose: This study evaluates the safety and efficacy of RA followed by cutting balloon angioplasty (ROTACUT) before stent placement in CAC.
Methods: A systematic review and meta-analysis of randomized controlled trials and observational studies was conducted.
Prog Cardiovasc Dis
December 2024
The Christ Hospital Heart & Vascular Institute and The Carl and Edyth Lindner Center for Research and Education, Cincinnati, Ohio, USA.. Electronic address:
The presence and severity of calcified coronary plaque negatively impacts angiographic and clinical outcomes following percutaneous coronary intervention (PCI). Severe coronary calcification is associated with suboptimal stent delivery, deployment, apposition and expansion which can lead to in-stent restenosis and/or thrombosis. Severe coronary calcification is associated with incremental hazard for adverse clinical events, including death, during 5-10 years following PCI despite the use of new generation drug- eluting stents.
View Article and Find Full Text PDFVascular
November 2024
Division of Diagnostic Imaging, Sheba Medical Center, Israel.
Objectives: The study aims to evaluate the safety and efficacy of the BeBack™ crossing catheter for percutaneous recanalization of lower limb chronic total occlusions (CTO) via tibial artery access in patients with chronic limb-threatening ischemia (CLTI).
Methods: This single-center, retrospective study included 21 patients who underwent 22 limb recanalization procedures between May 2021 and April 2024. The BeBack™ catheter was utilized after traditional methods of recanalization failed.
Catheter Cardiovasc Interv
November 2024
Department of Cardiology, Japanese Red Cross Ogawa Hospital, Saitama, Japan.
Calcified nodule (CN) is a high-risk phenotype of coronary artery calcification that causes in-stent restenosis frequently. Stent thrombosis (ST) is a critical complication following percutaneous coronary intervention, and its onset is associated with severely calcified lesions. However, the association between CN and ST remains unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!